About N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide
N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide (PubChem CID 155924273) has the molecular formula C41H38ClF6N9O5S
and a molecular weight of 918.32 g/mol. Its IUPAC name is N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide.
Analyze N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide?
The IUPAC name of N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide (CID 155924273) is N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide.
What is the SMILES notation for N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide?
The canonical SMILES for N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide is O=C(Cn1nc(C(F)F)cc1C1CC1)N[C@@H](Cc1cc(F)cc(F)c1)c1nc2cc(N3CCOCC3)ccc2c(=O)n1-c1ccc(Cl)c2c(NS(=O)(=O)C3CC3)nn(CC(F)F)c12.
What is the InChIKey of N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide?
The InChIKey is BCVRBGXHUUIZQI-HKBQPEDESA-N. The full InChI is InChI=1S/C41H38ClF6N9O5S/c42-28-7-8-32(37-36(28)39(52-56(37)19-34(45)46)53-63(60,61)26-4-5-26)57-40(50-29-17-25(3-6-27(29)41(57)59)54-9-11-62-12-10-54)31(15-21-13-23(43)16-24(44)14-21)49-35(58)20-55-33(22-1-2-22)18-30(51-55)38(47)48/h3,6-8,13-14,16-18,22,26,31,34,38H,1-2,4-5,9-12,15,19-20H2,(H,49,58)(H,52,53)/t31-/m0/s1.
What are the key properties of N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide?
N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide has a molecular weight of 918.32 g/mol, XLogP of 6.78, 15 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-1-[3-[4-chloro-3-(cyclopropylsulfonylamino)-1-(2,2-difluoroethyl)indazol-7-yl]-7-morpholin-4-yl-4-oxoquinazolin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[5-cyclopropyl-3-(difluoromethyl)pyrazol-1-yl]acetamide is sourced from PubChem (CID 155924273), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).